Teva to eliminate 14,000 jobs in major restructuring overhaul

The restructuring plan will also include the closure or divestment of a “significant number” of R&D facilities, headquarters and other Teva office locations across around the world.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.